Why biotech founders need multiple shots on goal unlike software startups

And, like, obviously, we can't prescribe it yet, but, like, do you can we learn something about it? Can so we can talk to our dog owners about it. One of the things we didn't get a hit on is the fact that you're actually a multi product business. Can you talk about the different products that you have and you're working on and just the timeline and kind of state of each one? One of the other things I would say is, like, very different about

biotech, versus software is you in software, like, generally speaking, you'll, like, start as a product. You'll, like, scale it out, and maybe you'll have, like, add on products. Right? But it's really like you have a core value prop. With the drugs, there's a couple different variables. But, basically, with drugs, I cannot make a drug work or not work. There is nothing I can do if Loy two does not work to make it work or if it's not safe. But I do know that our core thesis is correct, that a drug can extend a dog's healthy lifespan. And so one of the early decisions we made, which was, like, a bit controversial, but I think has worked out well for us, was we're gonna have multiple shots on goal on this same thesis.